ID

16770

Beschrijving

Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT00418054

Link

https://clinicaltrials.gov/show/NCT00418054

Trefwoorden

Versies (1)
  1. 05-08-16 05-08-16 -
Geüploaded op

5 augustus 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Chronic Hepatitis C NCT00418054

Engels

Eligibility Chronic Hepatitis C NCT00418054

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥18 years.
Beschrijving

age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
chronic hepatitis c infection (at least 6 months) evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.
Beschrijving

chronic hepatitis c infection evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.

Datatype

boolean

Alias
UMLS CUI [1]
C0524910
UMLS CUI [2]
C0086231
UMLS CUI [3]
C0166049
UMLS CUI [4]
C0369335
chronic inflammation on liver biopsy compatible with a diagnosis of chronic viral hepatitis.
Beschrijving

liver biopsy, chronic viral hepatitis

Datatype

boolean

Alias
UMLS CUI [1]
C0193388
UMLS CUI [2]
C0011900
UMLS CUI [3]
C0276623
hcv genotype 4.
Beschrijving

hcv genotype 4

Datatype

boolean

Alias
UMLS CUI [1]
C1148363
patients that have not previously received peginterferon.
Beschrijving

peginterferon

Datatype

boolean

Alias
UMLS CUI [1]
C0982327
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients unable to take oral medications.
Beschrijving

patients unable to take oral medications

Datatype

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C3494765
use of ribavirin within 30 days prior to enrollment.
Beschrijving

ribavirin

Datatype

boolean

Alias
UMLS CUI [1]
C0035525
females who are either pregnant, breast-feeding or not using birth control and are sexually active.
Beschrijving

pregnant or breastfeeding, contraception, sexually active

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
UMLS CUI [4]
C0241028
any investigational drug therapy within 30 days prior to enrollment other than through romark study number rm01-3027.
Beschrijving

investigational drug therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0162778
patients with other causes of liver disease.
Beschrijving

liver disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0015127
transplant recipients receiving immune suppression therapy.
Beschrijving

transplant recipients receiving immune suppression therapy.

Datatype

boolean

Alias
UMLS CUI [1]
C0376387
UMLS CUI [2]
C0021079
patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus based on enzyme immunoassay.
Beschrijving

patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus

Datatype

boolean

Alias
UMLS CUI [1]
C0275524
UMLS CUI [2]
C0019682
UMLS CUI [3]
C0019163
UMLS CUI [4]
C0376325
UMLS CUI [5]
C0011226
patients with decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.
Beschrijving

decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.

Datatype

boolean

Alias
UMLS CUI [1]
C1619727
UMLS CUI [2]
C0040034
UMLS CUI [3]
C0027947
UMLS CUI [4]
C0003962
UMLS CUI [5]
C0019151
patients with history of alcoholism (unless abstinent for 2 years) or with an alcohol consumption of >20 grams per day.
Beschrijving

alcohol consumption

Datatype

boolean

Alias
UMLS CUI [1]
C0001948
patients who are clinically unstable.
Beschrijving

clinically unstable

Datatype

boolean

Alias
UMLS CUI [1]
C0443343
patients with any concomitant condition that, in the opinion of the investigator would preclude evaluation of response or make it unlikely that the contemplated course of therapy and follow-up could be completed.
Beschrijving

comorbidity

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
history of hypersensitivity or intolerance to any of the excipients comprising the nitazoxanide tablets or peginterferon alfa-2b solution for injection.
Beschrijving

hypersensitivity to nitazoxanide or peg interferon alfa-2b

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0068788
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0796545
Terug naar het begin van de pagina

Similar models

Eligibility Chronic Hepatitis C NCT00418054

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age ≥18 years.
boolean
C0001779 (UMLS CUI [1])
chronic hepatitis c infection evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.
Item
chronic hepatitis c infection (at least 6 months) evidenced by a positive enzyme immunoassay for anti-hcv-antibodies and a positive quantitative rt-pcr amplification of hcv rna.
boolean
C0524910 (UMLS CUI [1])
C0086231 (UMLS CUI [2])
C0166049 (UMLS CUI [3])
C0369335 (UMLS CUI [4])
liver biopsy, chronic viral hepatitis
Item
chronic inflammation on liver biopsy compatible with a diagnosis of chronic viral hepatitis.
boolean
C0193388 (UMLS CUI [1])
C0011900 (UMLS CUI [2])
C0276623 (UMLS CUI [3])
hcv genotype 4
Item
hcv genotype 4.
boolean
C1148363 (UMLS CUI [1])
peginterferon
Item
patients that have not previously received peginterferon.
boolean
C0982327 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
patients unable to take oral medications
Item
patients unable to take oral medications.
boolean
C0175795 (UMLS CUI [1,1])
C3494765 (UMLS CUI [1,2])
ribavirin
Item
use of ribavirin within 30 days prior to enrollment.
boolean
C0035525 (UMLS CUI [1])
pregnant or breastfeeding, contraception, sexually active
Item
females who are either pregnant, breast-feeding or not using birth control and are sexually active.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0241028 (UMLS CUI [4])
investigational drug therapy
Item
any investigational drug therapy within 30 days prior to enrollment other than through romark study number rm01-3027.
boolean
C2348568 (UMLS CUI [1,1])
C0162778 (UMLS CUI [1,2])
liver disease
Item
patients with other causes of liver disease.
boolean
C0023895 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
transplant recipients receiving immune suppression therapy.
Item
transplant recipients receiving immune suppression therapy.
boolean
C0376387 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus
Item
patient co-infected with human immunodeficiency virus, hepatitis a virus, hepatitis b virus, or hepatitis d virus based on enzyme immunoassay.
boolean
C0275524 (UMLS CUI [1])
C0019682 (UMLS CUI [2])
C0019163 (UMLS CUI [3])
C0376325 (UMLS CUI [4])
C0011226 (UMLS CUI [5])
decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.
Item
patients with decompensated cirrhosis, thrombocytopenia (platelet count <80,000), neutropenia, history of variceal bleeding, ascites, hepatic encephalopathy or ctp scores >6.
boolean
C1619727 (UMLS CUI [1])
C0040034 (UMLS CUI [2])
C0027947 (UMLS CUI [3])
C0003962 (UMLS CUI [4])
C0019151 (UMLS CUI [5])
alcohol consumption
Item
patients with history of alcoholism (unless abstinent for 2 years) or with an alcohol consumption of >20 grams per day.
boolean
C0001948 (UMLS CUI [1])
clinically unstable
Item
patients who are clinically unstable.
boolean
C0443343 (UMLS CUI [1])
comorbidity
Item
patients with any concomitant condition that, in the opinion of the investigator would preclude evaluation of response or make it unlikely that the contemplated course of therapy and follow-up could be completed.
boolean
C0009488 (UMLS CUI [1])
hypersensitivity to nitazoxanide or peg interferon alfa-2b
Item
history of hypersensitivity or intolerance to any of the excipients comprising the nitazoxanide tablets or peginterferon alfa-2b solution for injection.
boolean
C0020517 (UMLS CUI [1,1])
C0068788 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0796545 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial